• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Prevalence of obesity among developed nations

Feature
Article

Antiobesity and T2D drugs are hot right now. Where are the markets for them?

The average national prevalence of obesity is 17.1% in developed nations around the world.

How does the United States match up with other countries? The Peterson-KFF Health System Tracker recently ranked 11 nations for the percentage of the population with a body mass index of 30 or more.

The analysis was included in a study by the Peterson-KFF Health System Tracker examining prices of the new diabetes and antiobesity treatments. Those new medicines have become one of the hottest trends in health care due to patients using them to lose weight.

The semaglutide drugs Ozempic and Rybelsus, used for type 2 diabetes treatment, and Wegovy, used for weight loss, and T2D medication Mounjaro (tirzepatide), could affect total health care costs of a nation. That will depend on the costs of the drugs themselves, and the number of people using them.

This slideshow lists obesity prevalence among 11 nations that are members of the international Organisation for Economic Co-operation and Development, an international partnership that promotes prosperity and equality across the globe.

Related Videos
© National Institute for Occupational Safety and Health
© National Institute for Occupational Safety and Health
© National Institute for Occupational Safety and Health
© National Institute for Occupational Safety and Health
© National Institute for Occupational Safety and Health
© National Institute for Occupational Safety and Health